COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,301 Articles (22,772 medRxiv, 8,529 bioRxiv)

Most recent first Previous |  Page 478: Articles 4771-4780  | Next

Analysis of SARS-CoV-2 mutations associated with resistance to therapeutic monoclonal antibodies that emerge after treatment.
Focosi, D., McConnell, S., Sullivan, D. J., Casadevall, A.
10.1101/2023.03.02.23286677 — Posted: 2023-03-02
The impact of early anti-SARS-CoV-2 antibody production on the length of hospitalization stay among COVID-19 patients
de Almeida, D. V., Cezar, P. A., Fernandes, T. F. B., Schwarz, M. G. A., Mendonca-Lima, L., Giacoia-Gripp, C. B. W., Cortes, F. H., Lindenmeyer Guimaraes, M., Pilotto, J. H., de Sa, N. B. R., Cazote, A. d. S., Gomes, L. R., Quintana, M. d. S. B., Ribeiro-Alves, M., Coelho, L. E., Geraldo, K. M., Ribeiro, M. P. D., Cardoso, S. W., Grinsztejn, B. G. J., Santos, V. G. V. d., Morgado, M. G.
10.1101/2023.03.02.23286693 — Posted: 2023-03-02
A novel approach for estimating vaccine efficacy for infections with multiple disease outcomes: application to a COVID-19 vaccine trial
Williams, L. R., Voysey, M., Pollard, A. J., Grassly, N. C.
10.1101/2023.03.02.23286698 — Posted: 2023-03-02
Association between spironolactone use and COVID-19 outcomes in population-scale claims data: a retrospective cohort study
Cousins, H. C., Altman, R. B.
10.1101/2023.02.28.23286515 — Posted: 2023-03-02
Use of a digital application to enhance communication and triage between care homes and National Health Service community services in the United Kingdom: a qualitative evaluation
Russell, S., Stocker, R., Cockshott, Z., Mason, S. M., Knight, J., Preston, N., Hanratty, B.
10.1101/2023.03.02.23286669 — Posted: 2023-03-02
COVID-19 or seasonal influenza? How to distinguish in people younger than 65 years old: A retrospective observational cohort study comparing the 2009 pandemic influenza A H1N1 with 2022 SARS-CoV-2 Omicron BA.2 outbreaks in China.
Zhong, W., Wu, Y., Yue, W., Fang, J., Xie, B., Xu, N., Lin, M., Zhu, X., Su, Z., Chen, Y., Li, H., Li, H.
10.1101/2023.02.28.23286466 — Posted: 2023-03-01
SARS-CoV-2 post-vaccine surveillance studies in Australian children and adults with cancer: SerOzNET Statistical Analysis Plan
Body, A. L., Martin, C., Busija, L., Lal, L., Ahern, E. S., MacIntyre, R. C., Segelov, E.
10.1101/2023.02.26.23286261 — Posted: 2023-03-01
Coarse-Grained Molecular Simulations and Ensemble-Based Mutational Profiling of Protein Stability in the Different Functional Forms of the SARS-CoV-2 Spike Trimers : Balancing Stability and Adaptability in BA.1, BA.2 and BA.2.75 Variants
Verkhivker, G., Alshahrani, M., Gupta, G.
10.1101/2023.02.28.530489 — Posted: 2023-03-01
Bulk RNA-Sequencing of small airway cell cultures from IPF and post-COVID lung fibrosis patients illustrates disease signatures and differential responses to TGF-β1 treatment
Uhl, K., Paithankar, S., Leshchiner, D., Jager, T., Abdelgied, M., Tripp, K., Peraino, A., Kakazu, M., Lawson, C., Chesla, D., Prokop, J., Chen, B., Murphy, E., Girgis, R., Li, X.
10.1101/2023.03.01.530431 — Posted: 2023-03-01
Type I interferon signaling induces a delayed antiproliferative response in Calu-3 cells during SARS-CoV-2 infection
Cunha, J. B., Leix, K., Sherman, E. J., Mirabelli, C., Kennedy, A. A., Lauring, A. S., Tai, A. W., Wobus, C. E., Emmer, B. T.
10.1101/2023.02.28.530557 — Posted: 2023-03-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).